Michael Carusi

Michael Carusi

Director/Board Member bei Emphasys Medical, Inc.

58 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

Mike is a General Partner and Team Leader of Lightstone Ventures (LSV) and focuses on investments in the biopharmaceutical and medical device sectors.
He is based in the firm’s Menlo Park, CA office, where he also serves as a General Partner at Advanced Technology Ventures (ATV).
His representative investments include Allay Therapeutics, Altura Medical (acquired by Lombard), Ardian (acquired by Medtronic), Cala Health, EndoGastric Solutions, Gynesonics, MediSix Therapeutics, MicroVention (acquired by Terumo), Nuvaira, Plexxikon (acquired by Daiichi Sankyo), PowerVision (acquired by Alcon), Second Genome, Shoulder Innovations, Tallac Therapeutics, and Willow.
Featured on the Forbes Midas List of top technology and life science investors, Mike is a recognized thought leader in the industry and a frequent speaker at healthcare conferences.
He serves as an Adjunct Professor at the Tuck School of Business Administration at Dartmouth College.
In addition, Mike has been heavily involved with several programs at Stanford University including the Stanford Biodesign Program and, more recently, the Stanford Center for Clinical and Translational Research and Education (Spectrum).
Lastly, Mike served as a Director on the National Venture Capital Association (NVCA) Board of Directors and remains active in helping to shape policy affecting both innovation and healthcare.
Earlier in his career, Mike served as a Director of Business Development for Inhale Therapeutic Systems (now Nektar Therapeutics, NASDAQ: NKTR), a venture-backed pulmonary drug delivery company that went public in 1994.
At Inhale, Mike led partnering activities with a number of pharmaceutical and biotechnology companies in the U.S., Europe, and Japan.
Mike also was a Principal at The Wilkerson Group, a leading management consulting firm focused exclusively on healthcare.
At The Wilkerson Group, Mike helped establish the firm’s offices in London and San Francisco.

Aktive Positionen von Michael Carusi

UnternehmenPositionBeginn
Private Equity Investor 01.01.1998
Director/Board Member 01.07.2001
Director/Board Member -
Director/Board Member 03.10.2011
Director/Board Member 03.10.2011
Director/Board Member -
Private Equity Investor 01.01.2012
Director/Board Member -
Director/Board Member -
░░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
Alle aktiven Positionen von Michael Carusi

Ehemalige bekannte Positionen von Michael Carusi

UnternehmenPositionEnde
░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
Sehen Sie sich die Erfahrung von Michael Carusi im Detail an

Ausbildung von Michael Carusi

Lehigh University Undergraduate Degree
Tuck School of Business at Dartmouth Masters Business Admin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Michael Carusi im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

27

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen1
NEKTAR THERAPEUTICS

Health Technology

Private Unternehmen23

Commercial Services

Health Technology

Health Technology

Electronic Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Electronic Technology

Distribution Services

Finance

Health Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Services

Foundry SING1, Inc.

Commercial Services

Finance

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Michael Carusi